Letter To the Editor: Severe gastrointestinal involvement in systemic lupus erythematosus treated with rituximab and cyclophosphamide (B-cell depletion therapy)

Grimbacher B. , Huber M. , Kempis J. et al. Successful treatment of gastrointestinal vasculitis due to SLE with intravenous pulse cyclophosphamide: a clinical case and review of the literature . Br J Rheumatol 1998; 37: 1023—1028 .

Janssen, Namieta , Genta et al. The effects of immunosuppressive and anti-inflammatory medications on fertility, pregnancy and lactation. Archives Int Medicine 2000; 160(5): 610—619 .

Lian TY , Edwards CJ , Chan SP , Chng HH Reversible acute gastrointestinal syndrome associated with active systemic lupus erythematosus in patients admitted to hospital . Lupus 2003; 12(8): 612—616 .

Ko SF , Lee TY , Cheng TT et al. CT findings at lupus mesenteric vasculitis . Acta Radiol 1997; 38(1): 115—120 .

Looney RJ , Anolik JH , Campbell D. et al. B-Cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose-escalation trial of rituximab . Arthritis Rheum 2004; 50(8): 2580—2589 .

Leandro MJ , Edwards JC , Cambridge G. et al. An open study of B lymphocyte depletion in systemic lupus erythematosus . Arthritis Rheum 2002; 46: 2673—2677 .

Leandro MJ , Cambridge G. , Edwards JC et al. B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patients . Rheumatology 2005; 44: 1542—1545 .